S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7129 +0.28%
PRE-MKT · 06:25 ET
Market ClerkRecap
Thu Oct 22 · pre-market2 signals on Oct 21108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead

ABT

ABBOTT LABORATORIES
NYSE · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
100.51
−1.94 −1.89%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $175.1BP/E 28.1DIV YIELD 2.43%FCF YIELD 4.21%REV TTM $45.1B +6.6%NET INCOME $6.3B −53.5%NET DEBT $6.1B52W 82.56 – 130.59SEC XBRL · TTM TO Invalid Date

What ABT had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
No 8-K filings from ABT on record yet. The events worker reads new filings each morning; older ones appear as the sweep reaches them.

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch ABT. Know when insiders buy.
One email the day a filing lands. Free.